Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 15Colorectal Neoplasms 13Lung Neoplasms 12Neoplasms 11Stomach Neoplasms 9Neoplasm Metastasis 6Colonic Neoplasms 6Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Osteosarcoma 3Multiple Myeloma 3Melanoma 3Lymphoma, Follicular 3Lymphoma 3Waldenstrom Macroglobulinemia 2Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Thymus Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2

Interventions

Blood Specimen Collection 6Liquid Biopsy 3Chemotherapy, Adjuvant 2trastuzumab deruxtecan 1pegaspargase 1Vincristine 1Trastuzumab 1Transplantation, Autologous 1Prednisone 1Neoadjuvant Therapy 1Methotrexate 1Mercaptopurine 1Hematologic Tests 1Drug Therapy 1Doxorubicin 1Daunorubicin 1Cytoreduction Surgical Procedures 1Cytarabine 1Cyclophosphamide 1Clonal Evolution 1Anti-Inflammatory Agents, Non-Steroidal 1Aminolevulinic Acid 1Ado-Trastuzumab Emtansine 1Adjuvants, Pharmaceutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasm, Residual × Drug Therapy × Clear all
NCT03491033 2018-04-10

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

Yonsei University

Completed
250 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡